Legal Issues

Merck appoints committee to review company actions on Vioxx

Published in Law and Health Weekly, January 1st, 2005

Beleaguered pharmaceutical giant Merck & Co. Inc. has appointed a special committee of board members and a retired federal judge to review the company's actions before it pulled its blockbuster arthritis drug Vioxx from the market.

Merck announced the special committee late December 7, 2004, saying it would act for the company's board of directors in handling shareholder litigation over the Vioxx withdrawal and would advise the board on any action to be taken after the review.

"This is exactly what you would expect the board to do in carrying out its duties to shareholders," said Merck spokeswoman Joan Wainwright.

She said the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law and Health Weekly

Source: Law and Health Weekly (2005-01-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry